Impact of the ventral hernia working group’s publication: a bibliometric analysis - Scorecard - MDSpire

Impact of the ventral hernia working group’s publication: a bibliometric analysis

  • By

  • Sara M. Maskal

  • Sergio Mazzola Poli de Figueiredo

  • Matthew Weaver

  • Mary Schleicher

  • Chao Tu

  • Ryan C. Ellis

  • Kimberly Woo

  • Aldo Fafaj

  • Daphne Remulla

  • Benjamin T. Miller

  • Clayton C. Petro

  • Lucas R.A. Beffa

  • Ajita S. Prabhu

  • Michael J. Rosen

  • June 18, 2024

  • 0 min

Share

Clinical Scorecard: Analysis of the Bibliometric Influence of the Ventral Hernia Working Group's Publication

At a Glance

CategoryDetail
ConditionVentral (incisional) hernia repair
Key MechanismsPatient risk factors for wound complications including comorbidities (smoking, obesity, diabetes, immunosuppression, COPD) and contamination level; mesh selection based on hernia grading
Target PopulationPatients undergoing ventral hernia repair with varying comorbidities
Care SettingSurgical and clinical research settings focused on hernia repair

Key Highlights

  • The 2010 VHWG publication introduced a 4-level grading system for ventral hernias based on patient risk factors and contamination level.
  • VHWG recommended biologic mesh for higher grade hernias (Grades 2–4) despite lack of randomized trials at the time.
  • Bibliometric analysis showed increased frequency of research on biologic mesh and comorbidities in ventral hernia literature post-VHWG publication.

Guideline-Based Recommendations

Diagnosis

  • Use patient comorbidities (smoking, obesity, diabetes, immunosuppression, COPD) and contamination status to grade ventral hernias.

Management

  • Select mesh type based on VHWG hernia grade, considering biologic mesh for Grades 2–4 hernias.

Monitoring & Follow-up

  • Monitor wound complications in patients with high-risk comorbidities undergoing ventral hernia repair.

Risks

  • Recognize that certain patient characteristics may increase risk of wound complications with permanent synthetic mesh.

Patient & Prescribing Data

Patients with ventral hernias and comorbidities such as COPD, smoking, diabetes, immunosuppression, and obesity

Post-2010 literature shows increased focus on biologic mesh use and comorbidity impact, reflecting VHWG publication influence on research priorities.

Clinical Best Practices

  • Incorporate patient risk factors and contamination level into hernia grading to guide mesh selection.
  • Consider biologic mesh for higher risk hernias as per VHWG recommendations, acknowledging limited randomized trial data.
  • Stay informed on evolving evidence regarding comorbidities’ impact on ventral hernia repair outcomes.

References

Original Source(s)

Related Content